pentoxifylline has been researched along with Colonic Neoplasms in 7 studies
Colonic Neoplasms: Tumors or cancer of the COLON.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentoxifylline (PTX) is a drug shown to have beneficial anti-inflammatory effects in cancer patients, mainly through anti-TNFα mechanisms." | 3.11 | PTX Treatment of Colon Cancer: Mode of Action Based on Tumor Marker and Cytokine Kinetics. ( Baider, L; Barak, V; Meirovitz, A; Peretz, T; Stephanos, S, 2022) |
| "Pentoxifylline (PTX) is a drug that has been shown to have multiple beneficial effects in cancer patients through its anti-inflammatory properties." | 3.01 | Effect of pentoxifylline on colon cancer patients treated with chemotherapy (Part I). ( Baider, L; Barak, V; Meirovitz, A; Peretz, T; Stephanos, S, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Meirovitz, A | 2 |
| Baider, L | 2 |
| Peretz, T | 2 |
| Stephanos, S | 2 |
| Barak, V | 2 |
| Lazarczyk, M | 1 |
| Grzela, T | 1 |
| Niderla, J | 1 |
| Lazarczyk, MA | 1 |
| Milewski, L | 1 |
| Dziunycz, P | 1 |
| Skopinski, P | 1 |
| Golab, J | 1 |
| Li, YX | 2 |
| Weber-Johnson, K | 2 |
| Sun, LQ | 2 |
| Paschoud, N | 2 |
| Mirimanoff, RO | 1 |
| Coucke, PA | 2 |
| Ching, LM | 1 |
| Browne, WL | 1 |
| Tchernegovski, R | 1 |
| Gregory, T | 1 |
| Baguley, BC | 1 |
| Palmer, BD | 1 |
| Kinuya, S | 1 |
| Yokoyama, K | 1 |
| Konishi, S | 1 |
| Li, XF | 1 |
| Watanabe, N | 1 |
| Shuke, N | 1 |
| Takayama, T | 1 |
| Bunko, H | 1 |
| Michigishi, T | 1 |
| Tonami, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical Study Evaluating the Anticancer Effect of Pentoxiphylline in Patients With Metastatic Colorectal Cancer[NCT06115174] | Phase 4 | 44 participants (Anticipated) | Interventional | 2023-11-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for pentoxifylline and Colonic Neoplasms
| Article | Year |
|---|---|
Effect of pentoxifylline on colon cancer patients treated with chemotherapy (Part I).
Topics: Aged; Antineoplastic Agents; Cachexia; Colonic Neoplasms; Disease Progression; Female; Fluorouracil; | 2021 |
PTX Treatment of Colon Cancer: Mode of Action Based on Tumor Marker and Cytokine Kinetics.
Topics: Anti-Inflammatory Agents; Biomarkers, Tumor; Carcinoembryonic Antigen; Colonic Neoplasms; Cytokines; | 2022 |
5 other studies available for pentoxifylline and Colonic Neoplasms
| Article | Year |
|---|---|
Differential influence of pentoxifylline on murine colon adenocarcinoma- and melanoma-derived metastatic tumor development in lungs.
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Lung Neoplasms; Melanoma; Mice; Mice, Inbred BALB C; Pen | 2004 |
Effect of pentoxifylline on radiation-induced G2-phase delay and radiosensitivity of human colon and cervical cancer cells.
Topics: Cell Cycle; Colonic Neoplasms; Female; G2 Phase; Gamma Rays; Humans; Pentoxifylline; Radiation-Sensi | 1998 |
Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid: concomitant reduction of serum tumour necrosis factor-alpha and enhancement of anti-tumour activity.
Topics: Animals; Antineoplastic Agents; Colonic Neoplasms; Drug Synergism; Mice; Neoplasm Transplantation; P | 1998 |
Potentiation of cytotoxicity and radiosensitization of (E)-2-deoxy-2'-(fluoromethylene) cytidine by pentoxifylline in vitro.
Topics: Antineoplastic Agents; Cell Cycle; Cell Survival; Cesium Radioisotopes; Colonic Neoplasms; Deoxycyti | 1999 |
Improved response of colon cancer xenografts to radioimmunotherapy with pentoxifylline treatment.
Topics: Animals; Antibodies, Monoclonal; Colonic Neoplasms; Humans; Mice; Microelectrodes; Neoplasm Transpla | 2001 |